周期过长通常是因为股权合伙人内部未能形成一致意见，而非收费律师未能说服客户。 对律所而言更难的地方在于结构：28名股权合伙人中有19名年龄在55岁或以上，且8年来没有正式的横向招聘计划或从助理到合伙人的晋升通道。因此任何可信方案都必须同时兼顾82%变现率和68%利用率，而这正是大多数内部分析停滞之处，因为这两个数据存在于不同系统。
周期过长通常是因为股权合伙人内部未能形成一致意见，而非收费律师未能说服客户。 对律所而言更难的地方在于结构：28名股权合伙人中有19名年龄在55岁或以上，且8年来没有正式的横向招聘计划或从助理到合伙人的晋升通道。因此任何可信方案都必须同时兼顾82%变现率和68%利用率，而这正是大多数内部分析停滞之处，因为这两个数据存在于不同系统。
周期过长很少是因为客户兴趣不足。它通常卡在某个具体阶段——事项反复停留的位置，而这个位置往往是收费律师需要向从未与客户接触过的股权合伙人说明决策。
这重新定义了解决方式。缩短周期主要在于给收费律师提供能在你不在场时赢得内部讨论的材料：变现率影响、利用率答案，以及与什么都不做的对比。
另一个常见原因是向无权批准支出的人推介，必须经股权合伙人同意。这不会显著延长周期，而是额外增加一个隐藏环节。
这三者同时出现才是标志。单独一个通常指向其他问题。
✓ 事项在五个业务组的同一阶段反复停滞
✓ 同一机会的预测日期反复推迟，拉长112天锁定周期
✓ 已流失事项的主要竞争对手是未获指示
通常会让情况更糟的做法。 增加对客户的跟进活动，这只会给收费律师施加压力，却没有提供任何能带给股权合伙人的新材料。
It is for you if you run or finance a law firm and deals consistently stall at the same stage. It is the situation where the numbers are available but nobody has put them in an order that produces a decision.
It is not for you if Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.
Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.
Below is an excerpt from a real run of this analysis on 一家律所. It is a sample profile rather than a customer, and it is engine output translated from English — this is the format you get, on your own numbers.
The subject is Ashgrove Legal LLP, a sample company profile used for testing rather than a customer — £24.8 m gross revenue from five practice groups.
Excerpt from a real Percision run · Competitive Positioning · sample company profile
The move. Scale the only practice hitting 88 % realisation to fund its own growth and close the succession gap.
| Investment required | £240 k (remaining FY2026 discretionary cap after £180 k IT commitment) |
| Expected return | 1.4–1.6× cash-on-cash within 24 months at current realisation rates. |
| Revenue, year 1 | £25.4–25.7 m firm-wide (+£0.6–0.9 m incremental) |
| Revenue, year 2 | £26.5–27.1 m firm-wide (+£1.1–1.3 m incremental from B&F segment) |
| Revenue, year 3 | £27.8–28.6 m firm-wide (+£1.3–1.5 m incremental) |
| Exit criteria | Strategy must be reversed if, within 18 months, segment revenue has not reached £2.4 m annualised OR cumulative net profit contribution is below £150 k, OR if any lateral hire’s personal billings fall below 1 200 hours in any rolling 6-month period. |
This is one move out of a full analysis. Read a complete report — every page, no email required.
This question routes to Go-to-Market & Commercial Strategy, one of 29 engagements the platform runs. For 律所 it works through 82 % realisation, 68 % utilisation, £184 k profit per equity partner and 112 lock-up days, then produces the sequence rather than a list of options — which move first, what it funds, and the observation that would say the sequence is wrong.
You watch the analysis get built before paying anything. 在此阅读完整报告 if you would rather see the depth first.
找出交易停留最久的阶段，明确买方在那里需要完成什么。这几乎总是内部审批，解决办法是提供材料而非说服。
这只会压缩最后一步，对周期前段的停滞毫无帮助，而时间主要消耗在那里。它还会让买方学会等待能获得回报。
不一定，如果交易规模和成交率能够支撑。它成为问题的前提是周期超出你的现金转换能力，这属于融资约束而非销售问题。
Materially, yes. 19 of 28 equity partners aged 55 or over with no formal lateral hire programme or associate-to-partner track for eight years — which changes both the diagnosis and the order of the fixes. The metrics that decide it here are 82 % realisation, 68 % utilisation, £184 k profit per equity partner, and an answer built on industry-general benchmarks will usually point at the wrong one first.
Less than most people expect. Your last twelve months of revenue and cost split the way you already split it, plus whatever you hold on 82 % realisation and 68 % utilisation. The analysis is explicit about what it is assuming where your data stops, which is more useful than waiting for numbers you may never have.
Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.
Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.
Describe the situation in your own words and we will tell you which analysis answers it — before you sign up for anything.
Describe my situation →Prefer to skip ahead? Go straight to the free diagnostic.
English · Español · Deutsch · Português · Français · Italiano · Nederlands · 日本語 · 한국어 · 中文 · Polski · Svenska · Türkçe · العربية · Tiếng Việt · ไทย · हिन्दी · עברית